Biotech News

by Jacob Bell on 10 Agosto, 2020 at 4:25 pm

The biotech's value more than quadrupled after reporting pivotal data that, according to executives, "substantially exceeded" what's needed for approval.

by Ned Pagliarulo on 10 Agosto, 2020 at 4:00 pm

Lawmakers questioned the timing of stock options granted to Kodak executives a day before the planned $765 million loan was announced. An SEC investigation is reportedly underway.

by Arlene Weintraub on 10 Agosto, 2020 at 2:39 pm

New insight into Down syndrome genes could inspire treatments for solid tumors arlene.weintraub Mon, 08/10/2020 - 10:39

by Susan Kelly on 10 Agosto, 2020 at 2:34 pm

The test, developed by Guardant Health, combines next-generation sequencing with a cancer blood test.

by Ben Adams on 10 Agosto, 2020 at 1:11 pm

AbbVie infectious disease exec jumps ship to COVID antiviral biotech badams Mon, 08/10/2020 - 09:11

by Arlene Weintraub on 10 Agosto, 2020 at 12:36 pm

GigaGen’s polyclonal antibody against COVID-19 outperforms plasma in lab tests arlene.weintraub Mon, 08/10/2020 - 08:36

by Ben Adams on 10 Agosto, 2020 at 11:08 am

Battered and bruised Seres Therapeutics see shares skyrocket on phase 3 win badams Mon, 08/10/2020 - 07:08

by Ben Adams on 10 Agosto, 2020 at 10:45 am

PPD squeezes out a revenue growth despite COVID-19 disruption badams Mon, 08/10/2020 - 06:45

by Ben Adams on 10 Agosto, 2020 at 9:29 am

Hits, but mostly misses for Roche’s 4 late-stage trials of GI drug hopeful etrolizumab badams Mon, 08/10/2020 - 05:29

by Helen Albert on 10 Agosto, 2020 at 5:00 am

It can pay to take your time and keep your options open when choosing a life sciences career. Henrijette Richter, Managing Partner at French VC Sofinnova Partners, knows this from her experience of becoming a successful biotech investor.  Richter started out as a scientist working in the industry and completed a PhD with the Danish pharma giant Novo Nordisk. After trying life as an academic researcher at MIT in the US, she decided it was not for her. Wanting to try something new with broad future options, she first moved into VC investment at the Danish firm Vækstfonden. Going back to her roots, she spent some years building up Novo Holdings and Novo Seeds, both investment arms of Novo Nordisk and its industrial biotech sister company Novozymes, before moving to Sofinnova Partners in Paris to become Managing Partner in 2014.  Her advice for a successful career is to take the time to make the right career decision and find a job that makes you happy. What made you get into investing? I was a postdoc at MIT from 2002 to 2004. One of the things I noticed while I was at MIT was that very few people came to work with a smile on their face and lots of them were still in the lab at 3 and 4 am. The post Keep an Open Mind for a Successful Career in Biotech  appeared first on Labiotech.eu.

on 10 Agosto, 2020 at 12:00 am

Seres Therapeutics announced positive topline data from the pivotal Phase III ECOSPOR III trial of its oral microbiome therapy SER-109 for recurrent C. difficile infection (CDI).

on 10 Agosto, 2020 at 12:00 am

Although August is a busy month on the U.S. Food and Drug Administration (FDA)’s calendar for PDUFA dates, this week’s dates were almost all approved ahead of schedule. Here’s a look.

on 10 Agosto, 2020 at 12:00 am

Maryland has become a key part of the strategy for Kite, a Gilead company, and its mission to find a cure for cancer.

on 10 Agosto, 2020 at 12:00 am

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 10, 2020.

on 10 Agosto, 2020 at 12:00 am

Convalescent therapy has been touted as a fast, effective response to COVID-19, but a new therapy by GigaGen Inc. could be even more promising.

on 10 Agosto, 2020 at 12:00 am

A Genentech investigational ulcerative colitis treatment etrolizumab posted mixed results in its late-stage study program in patients who have moderate or severe active forms of the disease.

on 10 Agosto, 2020 at 12:00 am

It was a moderately busy week for clinical trial news, with some particularly interesting announcements related COVID-19 vaccine trials. Here’s a look.

on 10 Agosto, 2020 at 12:00 am

Boston-based Verastem signed a definitive deal to sell its global commercial and development rights to Copiktra (duvelisib) to Henderson, Nevada and San Diego-based Secura Bio.

by Ben Fidler on 7 Agosto, 2020 at 9:25 pm

Approval of Evrysdi, from Roche and PTC Therapeutics, adds a third option for treating the neuromuscular disease, joining Spinraza and Zolgensma.

by Jacob Bell on 7 Agosto, 2020 at 4:22 pm

The agency's decision kicks off a historic and dramatic regulatory review, as significant lingering questions surround aducanumab's approval chances.

by Ben Fidler on 7 Agosto, 2020 at 3:45 pm

Development of EDIT-101, the first CRISPR-based therapy to be used in a company-led trial to alter genes within a person's body, will now move forward under Editas' sole ownership.

by Ned Pagliarulo on 7 Agosto, 2020 at 3:00 pm

With supplies of the in-demand drug tight, Gilead has enlisted Pfizer, along with companies across the globe, to churn out millions of treatment courses.

by Amirah Al Idrus on 7 Agosto, 2020 at 1:43 pm

Biogen nabs speedy FDA review for controversial Alzheimer’s drug aalidrus Fri, 08/07/2020 - 09:43

by Eric Sagonowsky on 7 Agosto, 2020 at 11:53 am

Chutes & Ladders—Alexion names Qadeer as first chief diversity officer esagonowsky Fri, 08/07/2020 - 07:53

by Angus Liu on 7 Agosto, 2020 at 9:54 am

How a protein promotes pancreatic cancer metastasis aliu Fri, 08/07/2020 - 05:54